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Puberty shifts emotional regulation and increases risky behaviour, including substance use, 
when young people are completing their education, making a transition to employment, and 
forming longer term intimate relationships. This systematic review of reviews considers the 
potential effects of alcohol, tobacco and illicit drug use during this period on: 1) social, 
psychological and health outcomes in adolescence and young adulthood; 2) role transitions, 
and later health and social outcomes of regular substance use initiated in adolescence; and 3) 
the offspring of young people.  We have looked for consistent support for causal relationships 
from different but complementary research designs and evidence of biological plausibility. 
Many adverse health and social outcomes have been associated with different types of 
substance use. The major challenge lies in deciding which are causal. There are also: 
qualitatively different harms associated with different substances; differences in the life stage 
at which these harms occur; and differences in the quality of evidence for different substances 
and health outcomes. The preponderance of evidence comes from a small number of high 
income countries so it is unclear whether the same social and health outcomes would occur in 
other countries and cultures. Nonetheless, enough harms are causally related to substance use 







The social transitions that occur during adolescence and young adulthood (the period from 
ages 10-24 years) are critical for a young person’s later life trajectories. As noted in paper 11 
of this series, this period of life is also when substance use typically starts, and patterns of use 
become established.  
The emotional shifts that accompany adolescence and young adulthood create opportunities 
and vulnerabilities.2 The process of puberty changes physical development, shifts emotional 
regulation and increases risky behaviours, such as, drug use. These risks occur at a time when 
young people are completing their education, making a transition into employment, and 
forming longer term intimate relationships. These transitions may be disrupted by substance 
use and the development of substance use disorders which often first emerge during 
adolescence. They commonly co-occur with, and complicate the course of, common mental 
disorders that also emerge in adolescence and young adulthood.3  
In this paper, we consider the potential effects of substance use during this period  on: 1) 
social, psychological and health outcomes during adolescence and young adulthood (i.e. 
consequences of intoxication and regular use); 2) social and health outcomes during the life 
course (i.e. outcomes of role transitions, and later health and social outcomes of regular 
substance use which is initiated in adolescence and sustained over years or decades); and 3) 
the offspring of young people who use substances. We focus on the substances that are most 
commonly used in this period, namely, alcohol and tobacco, and illicit drugs, particularly 
cannabis, amphetamines, cocaine and opioids (as described in paper 11  in this series). Our 
search strategy is summarised in panel 1 and in more detail in webappendix A. 
Panel 1: Search strategy 
Studies of the possible consequences of substance use in young people have been conducted 
almost entirely in high income countries. It is uncertain whether these consequences would be 
the same in: low and middle income countries; countries with very different cultures; and 
countries where the opportunities for young women differ markedly (see Panel 2). These are 
all important areas for future research.  




The uniqueness of adolescence and young adulthood 
 
In the past 20 years researchers have realised that neurodevelopment extends into the second 
and third decades of life. This realisation has heightened concern about the neurobiological 
vulnerability of adolescents to the adverse effects of regular substance use on cognitive and 
emotional development.  
Optimum cognitive abilities require healthy brain development. The primary motor and 
sensory areas (e.g. sensorimotor cortex and occipital pole) develop well before higher order 
brain centres involved in executive and emotional regulation. These processes are non-linear 
and show marked regional differences in the timing of synaptic growth and death.4 Cortical 
grey matter increases in volume in school age children. Cortical thinning then begins in the 
occipital and primary somatosensory cortex and continues into young adulthood as the 
prefrontal cortex matures.5 Brain white matter increases in volume and integrity in 
adolescence and young adulthood as connections form between the association cortices. 
Subcortical structures in the limbic system, including the amygdala and hippocampus, also 
increase in volume during adolescence.6  
Social and cognitive development: adolescents are not “little adults” 
In animals, puberty affects brain development; similar processes occur in humans.7  The 
clearest links in humans are with the maturation of subcortical structures involved in 
emotional processing: the amygdala, hippocampus and corpus striatum.8, 9   
Puberty is also linked to changes in social and emotional processing,10 and there is increasing 
focus on social and emotional development in adolescence.11 Social cognition - the ability to 
interpret the behaviour of peers and others – becomes more highly developed after puberty.12, 
13 Social cognition is central to good interpersonal functioning, mental health and well-being, 
educational attainment and, later, employment. In late childhood and adolescence, young 
people become especially sensitive to their social environments and to social cues. 
Experiences in this period may embed emotional and behavioural patterns.14 The prevalence 
of substance use in the young person’s peer group may have a major effect on their own 
substance use (see discussion of peer networks below). In addition, the extent of substance 
use in family members, including parents, can increase the risk of use, although it is unclear 
to what extent this reflects genetic, social or environmental influences (or a combination of 
all of these).15  
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Studies have identified parts of the brain involved in social and emotional processing during 
adolescence. The dorsomedial prefrontal cortex is involved in understanding the emotional 
and mental states of others and in reflecting on one’s status with one’s peers (see below).12  In 
functional magnetic resonance imaging (fMRI) studies, hormonal levels are associated with 
activity in cortical areas involved in socio-emotional processing, such as, anterior temporal 
cortex and medial prefrontal cortex.16The temporo-parietal junction, the posterior temporal 
sulcus, and the anterior temporal cortex are central to the acquisition of the social and 
emotional skills required for adult functioning. This reflects cortical changes, but white 
matter changes are also required for impulse control.17  
Cognitive skills, such as language and problem solving, are elaborated during adolescence 
and peak in the early to mid-20s.18 There is a growing capacity for sustained attention, 
extended working memory and increased inhibitory control of emotions, all of which 
facilitate goal-directed activities.19 Deficits in these cognitive skills are associated with a 
range of behavioural and emotional problems that emerge in late childhood and adolescence. 
The successful acquisition of these skills has long-term benefits for adult intellectual 
functioning, health and life expectancy.20, 21 
There is a range of studies that suggest that substance use during adolescence may have 
greater neuropsychological impact than substance use later in life, 22 with some suggestion of 
a greater sensitivity to neurotoxic effects23. Animal models have demonstrated that the 
adolescent brain is more vulnerable to the neurotoxic effects of substance use than the 
matured adult brain.24 Studies of human adolescents have to date been dominated by cross-
sectional study designs, making it harder to be confident the same effects occur in humans.   
It is also important to consider the relative impact of the rapidly changing psychosocial and 
emotional environment faced during adolescence, and how this may increase adolescent 
vulnerability to substance initiation and dependence. Emerging evidence from adolescent 
humans has begun to identify that particular brain regions (namely the ventromedial 
prefrontal cortex and the left inferior frontal gyrus, areas associated with emotional) may be 
able to discriminate between future substance users and their non-using peers. Importantly 
however, these brain regions have a modest impact on substance use initiation when 
considered in isolation.25 Other social and emotional developmental factors during this rapid 
period of development also appear to work in combination with neurobiological differences 




The importance of peer context for adolescents 
Adolescents’ decisions differ from those of older adults in assigning greater weight to peer 
acceptance and peer influence.26 Social and online media have dramatically extended the 
range of peer engagement in the time that young people may spend interacting with peers 
(see Panel 3).  
Panel 3: Potential impacts of social media 
The greater salience of peers is one reason why puberty is a risk period for substance use and 
problematic use.27 As noted in paper 11, affiliation with peers who use substances is one of 
the strongest and most consistent correlates of a young person’s substance use. If these 
associations do not reflect the influence of confounding covariates, there are two major 
explanations of this “peer-association” effect. Peer-socialisation theory posits that the 
behaviour of peers affects individuals’ actions, whereas peer-selection theory proposes that 
an individuals’ personality and substance use affects who they affiliate with28. Evidence from 
longitudinal studies suggests that both effects may be in play.  
Other factors may modify the influence of substance using peers.28 Peer association has larger 
effects on substance use in adolescents who: are younger; mature early; and have higher 
social anxiety, sensation seeking, and popularity.28 Peers have less impacts in those with 
more parental monitoring, more authoritative parenting and who spend more time with their 
families.28   
Changes in the structure of adolescence  
One of the most marked changes in recent decades is lengthening of the period during which 
the social transitions of adolescence occur, especially in high income countries. Adolescence 
has typically been framed as starting at puberty and ending with adult’ transitions into 
marriage and parenthood29. In many developed countries  the age of puberty has declined 
since early in the 19th Century30. At the same time in these countries, and increasingly in low 
and middle income countries, marriage and parenthood are occurring later in young adult 
life.31 These changes have expanded the risk period for substance use. Substance use (and 
other health risk behaviours) decrease once marriage and parenthood occur32 (see also paper 
11), so any delays in making these role transitions provide more time for heavier, riskier 





Assessing the effects of substance use in young people 
 
The impacts of substance use in young people might differ from those in adults for several 
reasons (see Panel 4). These are related to the unique social, cognitive and physical changes 
that accompany adolescence and young adulthood that were highlighted earlier.  
Panel 4: Why substance use in young people differs from substance use in older adults 
There is a challenge in deciding which of the adverse outcomes associated with substance use 
are caused by it because many of the risk factors for substance use and these adverse 
outcomes are shared. This complicates the task of attributing specific adverse outcomes in 
young adulthood to adolescent substance use.  
The research methods that can be used to address some of these challenges are summarised in 
panel 5. In general, when deciding whether a relationship is causal, we have looked for a 
confluence of evidence; that is, for consistent support for a causal relationship from different 
but complementary research designs that is supported by evidence of its biological 
plausibility. 
Panel 5: study designs that are used in assessing causal effects of substance use 
As noted in panel 2, governmental policies, and social and cultural factors, may affect some 
of the “harms” of substance use. For example, the risks of injecting drugs will be lower when 
clean injecting equipment is readily available, and information is provided on how to inject 
safely, than when needle sharing is common and levels of blood borne infections are high 
among older injectors. Similarly, young people who are arrested and imprisoned for illicit 
drug use may be exposed to other more drug-involved young people, and suffer the adverse 




The potential risks of substance use in young people 
 
The unique changes, transitions and position of young people affect the potential impacts of 
substance use. We can broadly describe three ways (“triple risks”) in which this may occur. 
First, during adolescence and young adulthood acute intoxication and the short-term effects 
of regular, heavy use can have adverse health and social effects. Second, substance use 
initiated then can have longer term impacts by disrupting social transitions to adulthood and 
entrenching sustained, heavy or dependent substance use that affects health in adulthood. 
Third, substance use can have adverse effects on the offspring of young adults.  We have 
summarised these in Table 1 and indicated the strength of evidence for these associations 
being causal. Webappendix B provides greater detail on the studies described in this section. 
The range of potential harms and the evidence differ between substances in multiple ways. 
There are: 1) qualitative differences in the harms of different substances (e.g. fatal overdoses 
vs. dependence); 2) differences in the life stage at which the harms occur (e.g. tobacco’s 
harms occur later in life while those of injecting drug use can occur much earlier); and 3) 
differences in the evidence on whether the harms are related to different types of substance 
use (e.g. case control studies vs longitudinal studies). A general limitation in this literature is 
that most evidence comes from high income countries. It is unclear to what extent the same 
social and health related outcomes would be seen in other countries and cultures. 
Table 1 about here 
 
1. Risks in adolescence and young adulthood 
Polysubstance use 
Young people who initiate early and regularly use one substance are much more likely to use 
others. In many high income countries, young people who begin using alcohol and tobacco in 
their mid-teens are much more likely to use cannabis; and early, regular cannabis users are 
more likely to use amphetamines, cocaine and heroin.33 Debate continues about how best to 
explain these patterns of drug involvement. One explanation is that the sequence reflects the 
effects of shared risk factors.34 This has most extensively been examined for cannabis, given 
that in high income countries it is the earliest illicit drug used (and the most common); 
adjustment for confounders attenuates but does not eliminate the relationship between regular 
cannabis use and the use of other illicit drugs.34-37  
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As noted in paper 11, in the World Mental Health Survey the order of initiation of substances 
varied greatly between countries.38 No one sequence of substance initiation predicted 
progression to use of other substances. Rather, it was the extent of any kind of substance use 
that predicted later use of other substances.38 
Road traffic accidents and other unintentional injuries 
Young people use alcohol and other drugs to experience their pleasurable intoxicating effects. 
Intoxication also increases risk taking, impairs judgment and psychomotor performance, and 
thereby increases the risk of injury if young people combine drug use with physical activities 
that include (but are not limited to) driving a car, swimming or climbing.  
Alcohol use is a well-established cause of injury in young adults.39 Case-control studies show 
a steep increase in the risk of road traffic accidents (RTA) with increasing alcohol 
intoxication; longitudinal studies show an increased risk of premature death from RTAs, in 
heavy-drinking young people, especially males40.  
There is less extensive but reasonable evidence that cannabis-impaired drivers have a higher 
risk of RTAs.41-44 The contribution of other illicit drugs to accidental injury has been less well 
studied. Evidence of illicit drug use is found in persons killed in RTAs45, 46, and people who 
use illicit drugs often report driving while intoxicated, but there have been very few case-
control studies or experimental studies that have separated the effects of illicit drug use on 
accident risk from the riskier behavior of persons who use these drugs.46, 47 Cigarette smoking 
is associated with accidental injuries in young people, but it is unclear whether this 
association can be explained by confounding factors.48  
Violence  
There is a consistent association between alcohol and some forms of illicit substance use49-51 
and violent behavior. Early studies attributed violence to the disinhibiting effects of substance 
use. More recently, however, studies have shown the need to consider the pharmacological 
effects of substance intoxication within a more complex network of biological, psychological 
and social factors. We discuss offending behaviour more generally below. 
Affective and anxiety disorders 
The risk of anxiety and affective disorders is elevated in individuals who use, or are 
dependent on cannabis, tobacco and alcohol.52-54 Cohort studies have also consistently 
demonstrated that use of these drugs are each strongly associated with later depression54. It is 
unclear whether these associations54 arise because: substance use predisposes individuals to 
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develop anxiety and depressive disorders; persons with these disorders use substances to 
alleviate their symptoms; or the associations arise from shared risk factors for substance use 
and these mental disorders.  
A number of longitudinal studies have sought to disentangle these causal hypotheses (see 
webappendix for detail). In some cohort studies of young people who use alcohol the 
association was wholly explained by common risk factors55, 56. One cohort found that 
symptoms of nicotine dependence influenced subsequent depressive symptoms, and common 
risk factors did not entirely explain this association.57 A meta-analysis of cohort studies of 
cannabis use and later depression found a modest increase in depressive disorders among 
regular cannabis users58, but most of these studies had not controlled for confounders, or 
excluded the possibility that depressed young people used cannabis to self-medicate.  
Intentional self-harm and suicide 
Heavy alcohol use is consistently associated with increased suicide risk in longitudinal 
studies, especially in young depressed males59, 60. A causal role for alcohol is plausible 
because its intoxicating effects may increase impulsive suicidal behaviour.   
Former and current smokers are more likely to report suicidal ideation than non-smokers,61 
and regular smoking is associated with a greater risk of suicide attempts.62-64 Twin studies 
suggest that the association between nicotine dependence and suicidal behaviour is not 
explained by familial risk factors.65 
A small number of case-control, cohort studies and twin studies have reported associations 
between cannabis use and suicide in adolescents and young adults, with inconsistent findings.66-
71 One meta-analysis58 concluded that the studies were too varied to meaningfully quantify risk 
and that most had not excluded reverse causation or controlled for confounding. There is poorer 
quality but very consistent evidence that suicide attempts and suicide deaths are highly elevated 
in people regularly using or dependent on other illicit drugs72-74 but these studies have not 
included adolescents. 
Psychotic symptoms and psychotic disorders 
An increasing number of studies have replicated associations between tobacco use and 
psychotic symptoms or disorder75, 76, including genetic studies.77A recent meta-analysis found 
an increased risk of first-episode psychosis in cigarette smokers.78  
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The evidence that heavy alcohol use causes psychosis is largely limited to case series of 
delirium tremens in severely alcohol dependent people,79 or psychotic disorders in heavy 
alcohol users. These typically occur after decades of sustained heavy drinking.  
A meta-analysis of cohort studies58 found that people who used cannabis regularly had twice 
the odds of psychotic symptoms as peers who did not. Reverse causation was addressed in 
some of these studies by excluding cases who reported psychotic symptoms at baseline, or by 
statistically adjusting for pre-existing psychotic symptoms. The common cause hypothesis 
was harder to exclude because the association between cannabis use and psychosis was 
attenuated after adjustment for confounders, and no study assessed all confounders58.  
There is strong experimental evidence80-82, confirmed by cohort studies of people using 
amphetamines83, 84, that amphetamine use has strong psychotogenic properties. A causal 
relationship is supported by animal studies showing that amphetamine affects dopaminergic 
neurotransmission in ways which have been implicated in psychosis.82 
HIV and other infectious diseases 
HIV infection is a risk for people who inject drugs, with the potential for rapid spread between 
injectors and to the wider community via sexual transmission.85 Hepatitis B and C viruses 
(HBV and HCV) are more efficiently spread by unsafe injection than HIV86, 87. HCV 
transmission is increasingly driven by injecting drug use. HBV is highly contagious through 
parenteral and sexual transmission routes. These risks can be substantially reduced by 
providing clean injecting equipment85, 88 (see paper 389 of this Series for a discussion of the 
evidence for these interventions). 
Infectious disease can also be spread through unsafe sexual activity, which is associated with 
substance use in young people. For example, alcohol is linked to risky sexual behaviour; in 
sub-Saharan Africa, alcohol and risky sexual behaviour are associated with HIV.90 The 
challenge is determining whether these associations are causal91 because there are many 
common risk factors for both sexual risk and substance use.  
Fatal and non-fatal overdose 
Overdose is causally related to substance use by definition. It is a risk for young people who 
use opioids, particularly if they also use CNS depressants such as alcohol and benzodiazepines. 
Fatal overdoses on stimulants are much rarer. It is difficult, if not impossible, to fatally 





Regular substance users who develop tolerance to a drug may experience withdrawal 
symptoms when they stop93, 94 struggle to control their drug use, and meet criteria for 
dependence. As noted earlier, there is debate about whether the criteria used to diagnose drug 
dependence in adults apply to adolescents and young adults.  
The risks of developing drug dependence vary with the drug and the route of administration.  
Nicotine and heroin are among the most addictive (in terms of the proportion of users who 
meet criteria for dependence, namely, 32% and 23% respectively). The dependence risks are 
lower for alcohol (15%), intranasal cocaine (15%), and cannabis (9%).95 
An early age of initiation to alcohol, tobacco, and cannabis use predicts a higher risk of 
substance use disorders. A plausible hypothesis is that early and regular use of drugs changes 
adolescents’ brain function in ways that increase dependence risk.96 A competing hypothesis 
is that early initiation is only an indicator of a higher pre-existing risk of problem drug use. 
The two hypotheses could both be true if early drug use acted on the brains of adolescents 
who are at higher risk of developing drug use disorders to increase that risk. In longitudinal 
studies, early initiation still predicts an increased risk of dependence but the association is 
usually attenuated after adjustment for confounders. Discordant twin studies have produced 
mixed results (see webappendix B).  
Cognitive impairment 
Given that significant brain development occurs in adolescence it is plausible that substance 
use in this period may affect synaptic pruning 30. Animal and f-MRI studies suggest that 
chronic nicotine exposure in adolescence affects attentional network functioning in the 
prefrontal cortex.97 However, these studies have used very small samples and so are not 
powered or designed to control for confounding factors.97, 98 It is also unclear whether 
tobacco use results in cognitive deficits or whether people with cognitive deficits use nicotine 
to cope with cognitive dysfunctions.98 
Sustained heavy alcohol use throughout adulthood can produce severe cognitive impairment 
from cumulative neurotoxic effects of ethanol and nutritional deficiencies secondary to heavy 
drinking.99 These disorders usually develop in mid to late adulthood after sustained heavy 
drinking over decades. It is unclear whether heavy alcohol use in adolescence can affect brain 
functioning in young adults in similar ways. Neuroimaging studies suggest that heavy 
drinking adolescents have more structural and functional brain abnormalities than low 
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drinking controls,96 but it is difficult to determine whether these changes reflect pre-existing 
differences, the effects of heavy drinking or some combination of the two.   
Case control studies have consistently found deficits in verbal learning, memory and attention 
in regular cannabis users, although it is unclear whether these cognitive functions fully 
recover after cessation of cannabis use and hence it is unclear whether these represent 
enduring changes in brain function.100 A recent longitudinal study suggested that sustained 
daily cannabis use over several decades can produce substantial differences in cognitive 
performance that may not be wholly reversible.101 Reviews of functional imaging studies of 
long-term cannabis users102, 103 have concluded that we need larger, better-controlled studies 
before definitive conclusions can be drawn. 
Educational attainment 
Alcohol, tobacco and illicit drug use in adolescence are correlated with poor school 
performance and early school leaving. A plausible explanation is that regular drug and 
alcohol use impairs learning but this interpretation is complicated because adolescents who 
use these drugs have lower educational attainments and educational problems before using 
drugs. They also are much more likely to affiliate with peers who are substance users and 
out-of-school, and they often want to make a premature transition to adulthood.104  
A substantial part of the association may be explained by shared risk factors.105, 106 
Nonetheless daily tobacco use prior to age 15 has been associated with poorer examination 
performance that persisted after controlling for confounders.107 In longitudinal studies, 
cannabis use before the age of 15 predicts early school leaving, and this association persists 
after adjustment for confounders.108-110 Twin studies suggest that the association is better 
explained by shared genetic and environmental risk factors for early cannabis use and early 
school leaving.111-113 The association between early onset alcohol use and later educational 
attainment is less consistent after adjustment for confounders.110   
Criminal activity 
There have been many studies showing associations between substance use and criminal 
activity, particularly for illicit drugs.114 Among the potential explanations are:115 1) the 
psychopharmacological hypothesis in which intoxication or withdrawal increase offending or 
young offenders use substances to facilitate offending); 2) an economic hypothesis that 
acquisitive crimes are committed to fund substance use; 3) a systemic hypothesis in which 
crime is generated by illicit drug markets; and 4) the common cause hypothesis in which 
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substance use and offending behavior reflect the effects of common causes. Reviews suggest 
common causes play a role but there is also evidence for all these hypotheses. 115   
 
2. Risks for role transitions and across the life course 
 
Employment 
Several longitudinal studies have demonstrated that early adolescent substance use is 
associated with reduced employment and stability, lower wages and poorer job 
satisfaction.116  Early initiation of use, use of illicit drugs and frequent substance use have 
been consistently associated with lower levels of employment, in men117 more than 
women.116 
There appears to be a dose response relationship between substance use and employment, 
whereby heavy, frequent users of substances are more likely to have negative employment 
outcomes.118 It is plausible that this association is mediated by lower educational attainment 
among early adolescent substance users.  
Financial independence 
There is consistent evidence that heavy, early onset substance use in adolescence is 
associated with higher rates of financial dependence in adulthood, compared to young people 
with low rates of, or no substance use.117 For example, Fergusson et al 67, 119 report higher 
rates of unemployment and welfare dependence in regular cannabis users, and these findings 
persisted even after adjustment for childhood, family and related factors. It is likely that the 
association between early onset substance use and decreased financial independence is 
closely linked to lower educational attainment and employment outcomes among early 
substance users. There has been some suggestion that early onset substance use increases the 
likelihood of adopting a lifestyle characterised by disengagement from social norms, such as 
completing an education and entering the workforce.117 
Family formation 
Substance use during adolescence may adversely affect interpersonal relationships and family 
formation for several reasons. Firstly, adolescent substance use may produce a 
‘developmental lag’ whereby young people become entrenched in thinking and coping styles 
that impair their ability to form close interpersonal relationships. Secondly, the relationship 
between early substance use and risky sexual activity, early school dropout and higher rates 
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of unemployment may increase the likelihood of relationship failure. There is consistent 
evidence that cannabis use in young people is associated with greater relationship problems, 
including lower levels of relationship satisfaction,119, 120 reduced likelihood of marriage 
compared to non-users121 and reduced likelihood of residing with one’s spouse.120 There is 
some evidence among existing smokers that heavy and increasing tobacco use across early 
adolescence to adulthood is associated with greater problems in interpersonal relationships in 
early adulthood. 121Similarly, there is some evidence that binge drinkers who steadily 
increase their use across early adolescence are less likely to be married by age 23 than those 
who decrease their use over time.121 
 
Physical health consequences 
The physical health effects of substance use later in adult life are among the biggest 
contributors to health loss. These are the distal consequences of substance use initiated in 
adolescence and young adulthood, which persists into later life. It is in the later decades of 
life that the health consequences of tobacco smoking and alcohol use become apparent; the 
effects of illicit drug use occur earlier in adult life.122 
It is beyond the scope of this review to review the health consequences of long term tobacco 
and alcohol use. Tobacco smoking over decades is an important cause of multiple cancers, 
cardiovascular disease, chronic respiratory disease and a range of other non-communicable 
diseases123. Similarly, heavy alcohol use over decades increases risks for a range of cancers, 
cardiovascular disease, cirrhosis of the liver, diabetes and a range of other non-communicable 
diseases124. 
There is less evidence on the long-term physical health effects of illicit substance use91. 
Stimulant drugs have been associated with cardiovascular problems125 but the quality of 
studies is very poor. The general physical health of long term opioid and stimulant users is 
often very poor but almost no studies control for the confounding effects of other lifestyle 
risk factors, including alcohol and tobacco use.91 
The strongest evidence for physical health consequences of long-term, regular cannabis 
smoking is for chronic bronchitis.126 There is inconsistent evidence on long-term cannabis’ 
effect on respiratory function126. Recent reviews have concluded that there is still insufficient 
evidence on respiratory, or head and neck cancers.127 Evidence for other long-terms health 
outcomes of cannabis is even weaker. 
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3. Risks for the next generation 
 
There has been considerable research on the risks of substance use during pregnancy for the 
unborn baby. Maternal smoking during pregnancy is associated with poorer psychomotor 
development in childhood and poorer academic achievement and behavioural problems128, 
independently of other variables.  
Recent reviews on the effects of low or moderate alcohol consumption during pregnancy are 
inconclusive.128 Very heavy or dependent drinking is associated with adverse impacts upon 
offspring and children via low birthweight and foetal alcohol spectrum disorder (FASD)124. 
There are inconsistent effects of pre-natal exposure to cannabis use on outcomes in babies and 
children. The causal interpretation of any such effects is weakened by the limited ability of these 
studies to control for the confounding effects of other drug use during pregnancy, poor 
parenting, and genetic factors.126 
There are also a range of other risks that are associated with heavy substance use by parents. 
These include exposure to trauma, less adaptive parenting styles, exposure to the substance 
use of parents and a range of other potentially negative events that may impact upon children. 
In the most part, the studies of this issue have been of parents with identified substance use 





The increasing importance of substance use in the global health agenda for 
young people  
 
As discussed in paper 11, substance use is a considerable contributor to health burden during 
adolescence and young adulthood in the Global Burden of Disease (GBD) studies. Substance 
use is increasing in many low and middle income countries. This is particularly the case for 
tobacco and alcohol, the health and social consequences of which may not be seen for some 
decades. There is explicit acknowledgement of the importance of addressing young people’s 
substance use in key UN agendas. These include the Commission on Narcotic Drug’s 2009 
political declaration and plan of action to address “the world drug problem”130, WHO’s 
framework on tobacco control131 and WHO’s global strategy to reduce harmful use of 
alcohol.132 Paper 389 provides a review of existing scientific evidence on a range of 
responses that have been used to address substance use in young people. 
Our review has further considered the potential health and social consequences of young 
people’s substance use using a life course perspective; these kinds of impacts are not as 
clearly reflected in GBD metrics. Our review of this evidence suggested that substance use 
may have impacts across many domains during adolescence and young adulthood. It can also 
have effects throughout adult life, via its impact on role transitions and milestones, and via 
the delayed health effects much later in life. These include a range of health and social 
outcomes that loom large on the international health and social agenda. We highlight several 
important examples of these below.  
First, the sexual and reproductive health of young women has been emphasised133 in the 
WHO Global Strategy for Women’s, Children’s and Adolescents’ Health, 2016-2030.134 
Substance use may be an important risk factor for sexual risk taking, unintended pregnancy, 
sexually transmitted infections, and sexual violence. Very heavy substance use during 
pregnancy may affect the offspring of young women.  
Second, young people who are heavily involved with substance use have higher risks of self-
harm, suicide and mental disorders, such as depression and anxiety, and rarer but highly 
disabling disorders such as schizophrenia and other psychotic disorders (e.g. heavy 
amphetamine and cannabis use). Suicide and mental disorders feature prominently in the 
WHO’s strategy regarding adolescents noted above134, but also in the WHO’s Mental Health 




Third, the recent UNAIDS Strategy 2016-2021137 focuses on young people. As documented 
in this review, injecting drug use and heavy episodic alcohol use have both been linked with 
HIV risk. The magnitude of these risks varies geographically and with variations in HIV 
prevalence in the population and among people who inject drugs. Similarly, the extent to 
which knowledge, access and stigma affect risk taking, and access to risk reducing 
interventions varies widely across countries and cultures (as discussed in paper 389). 
Research priorities 
This review has highlighted major gaps in evidence. First, neuroscientific research suggests 
that young people may be especially vulnerable to the effects of substance use for multiple 
reasons.23 However, much of this research in humans has not been of a sufficient standard to 
assess whether there are particularly elevated risks of substance use at this age (as opposed to 
at older ages). There is a pressing need for more sophisticated research designs, especially 
prospective studies, that integrate neuroimaging and genetics to understand relationships 
between adolescent substance use and adult health outcomes (e.g.138). These studies should 
be done with a view to developing simpler assessment methods that can be used in low and 
middle income countries.  
Second, many potential outcomes of substance use have been the subject of limited research. 
Third, the research that has been done has often used research designs poorly suited to 
assessing causality. Fourth, the geographic coverage of research is poor. This is a major 
obstacle to drawing of firm conclusions on causal impacts, given that many of the 
confounding factors involve social, cultural and interpersonal variables that vary widely 
between different countries and cultures. There is a clear need for well-conducted prospective 
studies of the health and psychosocial consequences of adolescent and young adult substance 
use in more diverse cultural and social settings than the small number of high income 
countries in which these studies have been done to date. 
Finally, as has hopefully become evident in this paper, the impacts of the substance use on 
the unique transitions and changes that occur during this period may reach across the life 
course and affect the next generation. Research on substance use in young people to date has 
been short term and individually-focused. Future work should examine longer-term, social 
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Panel 1: Search strategy 
We conducted a systematic review of reviews in Pubmed and Web of Science using search terms pertaining to 
substance use, young people, and health and social outcomes since 1990 (see webappendix A for search terms 
used). from 1990-present. We searched for reviews of substance use among those aged 10-24 years (see paper 1 
and http://www.un.org/esa/socdev/documents/youth/fact-sheets/youth-definition.pdf). EMBASE and Psycinfo 
were screened for material not indexed by Pubmed and Web of Science.   
Peer-reviewed articles were initially assessed on the basis of title and abstracts, and those identified to be 
relevant were reviewed in full. The search strategy is included in webappendix A. Where relevant reviews were 
not available the addressed a particular health or social outcome, we conducted additional searches for good 
quality empirical studies and reviewed major books and grey literature reports e.g.139. 
Limitations of our search strategy 
Although our search strategy was very wide in scope, it is important to acknowledge some limitations of the 
strategy. We did not search every database systematically, but concentrated on the largest two, with 
supplementary searches of others. Having said that, there is huge overlap between most of the remaining 
databases, such that it is unlikely that we missed any major systematic or other literature reviews of the potential 
consequences of substance use in young people. Additionally, where no reviews were located for a specific 
potential consequence of substance use, we supplemented this search with searches for empirical papers on the 
topic. 
Second, we drew on grey literature sources including government reports and books, however we did not 
conduct a full systematic web search for these. To do so would have been an overwhelming task that was out of 
possibility for this review, however we did rely on more reputable sources for grey literature that should have 
capture the better conducted reviews of this topic, and contained more high quality reviews. 
Third, we concentrated on reviews conducted since 1990. This may have missed reviews conducted in earlier 
years, however since we focused on a review of reviews approach, older empirical literature (i.e. pre-1990) is 
still included in many reviews, particularly the higher-quality research. 
Finally, although not a limitation of our search strategy, it is important to note that there is considerable 
variation across studies in the way in which confounding is considered statistically, and in the range of variables 
considered as potential confounders, when empirical studies are considering whether there is support for a 




Panel 2: Cross-national differences in consequences of substance use? 
• Nearly all the evidence on the correlates of substance use in young people has come from high income 
countries. This limits our understanding of the health and social consequences of substance use in young 
people as follows. 
• Varied societal experiences of adolescence: The role, experience and length of the adolescent period 
varies widely between countries and cultures. 
• Variation in the roles of young women: The social status and role of young women varies significantly 
between countries. Young women in some low and middle income countries have lower levels of 
education, and higher rates of teenage or very young adult marriage, and early pregnancy. 
• Variations in policy and social responses to substance use: The legal and cultural response to substance 
use differs across countries. For example, risks of exposure to blood-borne viruses is far higher among 
young people who inject drugs in some countries than others140 because preventive interventions such as 
needle and syringe programmes are not available,141-143 and injecting drug use is stigmatised, increasing fear 






Panel 3: Social media, substance use and risk behaviour in young people 
• In most countries there has been a dramatic increase in mobile technology coverage, with  over 2 billion 
smartphones estimated to be in circulation in 2016144.  
• Large numbers of people access the internet using mobile devices145, with young people the highest users of 
online and social media in high income countries146. For example, 97% of Australian 8-17 year olds145 use 
the internet and more than 90% own a mobile phone.145 Most have email accounts, and interact via multiple 
apps such as Facebook, Instagram, Snapchat and Tumblr.  
• New media can benefit young people by enhancing communication and social connectedness.147  
• But new media also carry risks: young people are especially susceptible to media because of their 
developing identities, the influence of peer relationships and their greater impulsivity.97 New media also 
allow the rapid disseminate of messages – accurate or not - to large groups of young people.  
• Young people may be especially susceptible to marketing of tobacco and alcohol via social media.148, 149  




Panel 4: Why substance use in young people differs from substance use in older adults  
• Substance use in adolescents and young adults differs from that in older adults in a number of ways that 
may affect the nature and magnitude of any adverse effects of substance use.  
• First, the same pattern of use may have different effects because of differences in physical development and 
in social and developmental contexts of adolescents, younger and older adults.  
• Second, young people’s inexperience might increase the adverse effects of acute intoxication because of a 
lack of understanding about doses required to obtain the desired effect. Older adults have more experience 
in titrating doses.  
• Third, the shorter period of use means that young people are less likely than older adults to have 
entrenched, dependent patterns of substance use (although this can certainly occur). Young people’s 
understanding of many of the symptoms of the “dependence syndrome” appears to differ from that of older 
adults (see paper 1), requiring more nuanced methods of assessment of dependence.  
• Fourth, animal research suggests that substance use during adolescence may increase vulnerability to 
dependence23 because of greater impacts on some areas of the brain (e.g.152). This research has support from 
cross-sectional case-control studies in adolescent humans but needs to be strengthened by prospective study 
designs. 
• For all of these reasons, we need evidence on the nature and magnitude of consequences of substance use in 




Panel 5: Study designs used to examine associations between substance use and 
outcomes 
• Causal inferences about the effects of any substance use require evidence that:  
 (1) substance use and the outcome are associated; 
 (2) reverse causation is unlikely; and  
 (3) shared risk factors do not provide a plausible explanation of the association.153 
 
• Some of the study designs that can be used to assess these issues are summarised below. 
 
• Case-control and prospective studies can establish (1) and prospective studies can help to resolve (2) but 
(3) remains major challenge because experimentation is rarely ethically acceptable.  
 
• Statistical analyses of prospective studies can adjust for differences between drug users and non-users.   
 Limitations:  Studies may not have measured all confounders or measured them with error, and so are 
 unable to fully control for their effects. 
• Genetic studies: Identical and fraternal twin pairs who differ in drug use can be used to separate the effects 
of shared genetic and shared environmental risk factors. 
 Limitations: They cannot control for non-shared environmental risk factors e.g. peers.  
• Mendelian randomisation uses genotypic information to test whether an observed relationship154 is causal. 
 Limitations: It requires a genotype that is common, associated with exposure but not with the health 
 outcome. Such genotypes may not exist.  
• Neuroimaging studies can show correlations between drug use and changes in brain function in regions 
implicated in cognitive and emotional functioning.  
 Limitations: Most of these are small case-control studies so it is difficult to decide which is a cause, and 
 which an effect of drug use.  
• Animal models can assess the biological plausibility of causal relationships by studying the effects of drugs 
on the behavior and brains of peri-pubertal and adult animals. 
 Limitations: Uncertain relevance to human substance use because of interspecies differences in 




Table 1: Evidence on the potential “triple risks” of substance use (during adolescence, across adulthood and for the next generation) for 
young people’s well-being 
 
 Tobacco Alcohol Cannabis Other illicit drugs* 
 Associated? Likely 
causal? 
Source Associated? Likely 
causal? 
Source Associated? Likely 
causal? 
Source Associated? Likely 
causal? 
Source 
Risks in adolescence and young 
adulthood  
            
Mental and behavioural             
Polysubstance use  B 155  B 153  B 35-37, 155-157  D 157 
Substance dependence   A 158-160  A 50, 161-163  A 156, 164, 165  A 165 
Depression  B 146  B 56, 166-168  B 52, 53, 169  C 169 
Anxiety   B 146, 170  B 171  B 58, 164, 169  C 169 
Psychotic symptoms/induced psychosis  B 75, 76, 78  B 146  A 58, 82, 172  A 80, 81, 169, 173 
Violence  - -  B 49-51  D 144  C 144 
Risky sexual activity  - -  B 161, 174, 175  D   C 176 
Intentional self-harm  - -  B 59, 60  ? B 66-69, 164, 177  C 32 
Suicide  B 61-64  B 50, 59, 161, 162, 177-179  ? B 66-69, 164, 177  C 72-74 
Physical             
Fatal overdose  - -     - -  A  
Road traffic accidents  - -  A 50, 57, 161, 162  A 41-44, 164, 180  C 42, 44 
Other accidental injuries  D 48, 145  A 124  D 181  C 32 
Sexually transmitted infections  - -  ? C 139, 182  - 183  B 32, 176 
HIV, HCV, HBV  - -  ? B 182  - 183  A 176, 184, 185 
Cognitive impairment  E 97, 98   99  B 10, 186-188  C 32 
Social and other             
Lower educational attainment   B 106, 107, 189  B 161, 189  B 104, 108-110, 157  C 108, 157, 189 
Criminal activity  - -  ? C 161  ? C    ? C 114, 115 




Notes on codes used in this table 
Presence or absence of effect 
 This drug not appear to have a significant effect upon the outcome 
 This outcome may be increased by the use of this drug 
n/a not applicable 
?  There is insufficient data on this drug and this outcome to permit conclusions about the 
association between the two 
Level of evidence 
A  Experimental or controlled evidence supports this finding 
B Findings across cohorts, representative population-based 
C Findings across cohorts of substance users 
D    Findings across cross-sectional studies, representative population-based, or case-control studies  





Table 1 (continued) 
 
 Tobacco Alcohol Cannabis Other illicit drugs* 
 Associated? Likely 
causal? 






Source Associated? Likely 
causal? 
Source 
Risks for social role transitions and 
across the life course  
            
Social and other             
Employment  - -  - -  B 67, 171  C 116, 118 
Financial independence  C 121  C 121  # 187  C  
Family formation  - -  C 39, 121  D 187  ? C  
Mental and behavioural             
Substance dependence   A 158-160  A 95  A 156, 164, 165  A 95 
Depression  B 146  B 56, 166-168  B 52, 53  C 169 
Anxiety   B 146, 170  B 171  C 58, 164, 190  C 169 
Psychotic symptoms/induced psychosis  B 75, 76, 78  B 146  A 58, 82, 156, 172, 191  A# 80, 81, 169, 173 
Intentional self-harm/suicide  - -  B 59, 60  ? B 187  B 72-74 
Physical             
Cardiovascular diseases  A 123  B 192  C 186, 187  C 32 
Cancers  A 123  B 192  C 186, 187  C (injecting) 193 
Chronic respiratory disease  A 123  - -  C 186, 187  ? C 194 
Cirrhosis  - -  B 128  - -  B (injecting) 193 
Diabetes and endocrine diseases  - -  B 192  - -  - - 
Other non-communicable diseases  A 123  B 192  - - ? - - 
Skin and subcutaneous diseases  - -  - -  - -  C (injecting) 195 
Risks to the next generation             
Maternal reproductive health  A 181  B 48  C 48, 156  C 48, 156 
Neonatal outcomes  A 196  B 197  B 187  C% 123 
Child outcomes  A 196, 198 ? B   C 187  C% 127 




Notes on codes used in this table 
Presence or absence of effect 
 This drug not appear to have a significant effect upon the outcome 
 This outcome may be increased by the use of this drug 
n/a not applicable 
?  There is insufficient data on this drug and this outcome to permit conclusions about the 
association between the two 
Level of evidence 
A  Experimental or controlled evidence supports this finding 
B Findings across cohorts, representative population-based 
C Findings across cohorts of substance users 
D    Findings across cross-sectional studies, representative population-based, or case-control studies  
E Cross-sectional associations among non-representative samples of substance users, case series 
suggesting outcome 
 
 
